SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.
Frans Cromme, Chief Executive Officer of ViCentra, said: "We aim to deliver the best user experience as well as excellent clinical results with our Kaleido insulin pump and our partners. Kaleido with ...
The hybrid closed loop system predicts high and low blood sugar levels and adjusts insulin delivery accordingly throughout the day, while still allowing the user to manually bolus for meals. In ...
SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod Horizon. It is designed to be compatible ...
The algorithms in Tandem's investigational Control-IQ system include special triggers to prevent low blood sugar and additional insulin control overnight while the user is sleeping. (Tandem Diabetes ...
Kaleido is one of the world's smallest and lightest insulin patch pumps, with a low ecological footprint due to its reusable design Paired with the Diabeloop DBLG1 control software and Dexcom G6 CGM ...
SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod Horizon. It is designed to be compatible ...
ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest insulin patch pump systems for managing type 1 diabetes, is pleased to announce the launch of a Hybrid Closed Loop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results